
Rxedia Meditech Private Limited
About Rxedia Meditech Private Limited
Data last updated:
Rxedia Meditech Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 27 September 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U72300MH2011PTC222452.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Babaljit Kaur and Sarbpal Chitwarn Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 43 Surya Shopping Center Srishti Complex Mira Road (E), Thane, Maharashtra, India – 401107.
As per the financials filed for FY 2024, the company reported a revenue of ₹21,466, a decline of 4% compared to the previous year. For the same year it recorded a net profit of ₹2,489 (net margin 11.6%) and EBITDA of ₹2,489 (EBITDA margin 11.6%). Revenue has declined at a compounded annual rate (CAGR) of 59% over three years and 41% over five years.
The company is associated with 1 brand: Rxedia.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Rxedia Meditech Private Limited's registered office is in Thane, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered Address43 Surya Shopping Center Srishti Complex Mira Road (E), Thane, Maharashtra, India – 401107
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
To see the full contact details of Rxedia Meditech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Rxedia Meditech operates one associated brand: Rxedia. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Free tool for effortless patient and clinic management activities. | rxedia.com |
Business activity
The main business activity of Rxedia Meditech is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Rxedia Meditech Private Limited, buy the company report.
Financials of Rxedia Meditech Private Limited
FY 2025 filings availableRxedia Meditech Private Limited reported revenue of ₹21,466 (down 4% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 41% over five years, including a 4% fall in the latest year. EBITDA fell 29% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2,489 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2,489 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.6% | ||||
| Net Profit Margin | 11.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Rxedia Meditech Private Limited, buy the company report.
Board of directors of Rxedia Meditech Private Limited
Rxedia Meditech has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Babaljit Kaur | Director | 27 Sep 2011 | 15 Years 1 Months | Current |
| Sarbpal Chitwarn Singh | Director | 27 Sep 2011 | 15 Years 1 Months | Current |
| Amritpal Chitwarn Singh | Director | 27 Sep 2011 | 15 Years 1 Months | Current |
Auditor
Rxedia Meditech Private Limited is audited by RITESH BURAD & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RITESH BURAD & CO | FY 2020 | 117936W |
Shareholding
The shareholding of Rxedia Meditech Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Rxedia Meditech Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Rxedia Meditech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rxedia Meditech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Rxedia Meditech Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Rxedia Meditech Private Limited has 3 board changes on record since 2011: 3 appointments. The latest: Amritpal Chitwarn Singh was appointed as Director on 27 Sep 2011.
Frequently asked questions
Rxedia Meditech is an active private limited company based in Thane, Maharashtra, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 27 September 2011 (15+ years old) and is registered under CIN U72300MH2011PTC222452.
Rxedia Meditech has 3 current directors:
- Babaljit Kaur - Director
- Sarbpal Chitwarn Singh - Director
- Amritpal Chitwarn Singh - Director
The latest financial statements of Rxedia Meditech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Rxedia Meditech is U72300MH2011PTC222452. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rxedia Meditech was incorporated on 27 September 2011, making it 15+ years old. It is registered with the Registrar of Companies, Mumbai.
Amritpal Chitwarn Singh was appointed as Director on 27 Sep 2011. Babaljit Kaur was appointed as Director on 27 Sep 2011. Sarbpal Chitwarn Singh was appointed as Director on 27 Sep 2011.
The registered office of Rxedia Meditech is at 43 Surya Shopping Center Srishti Complex Mira Road E, Thane, Maharashtra, India – 401107.
Rxedia Meditech operates in the healthcare industry, in the diagnostic centers and pathology labs segment.
The compliance status of Rxedia Meditech is compliant as of 15 August 2026. The company is actively filing with the Registrar of Companies.
Rxedia Meditech has 1 associated brand: Rxedia.

